STAA
STAAR Surgical Company · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth -16.7% ·
share flow -21.6% ·
net new positions -20.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +6 | 22.78M | $653.08M | +13 | −6 |
| Q1 2026 | 71 | -2 | 21.75M | $407.04M | +10 | −12 |
| Q4 2025 | 73 | +2 | 25.59M | $590.84M | +2 | — |
| Q3 2025 | 16 | +2 | 16.83M | $452.11M | +3 | −1 |
| Q2 2025 | 11 | 0 | 16.25M | $272.61M | — | — |
| Q1 2025 | 8 | -2 | 3.84M | $67.78M | +1 | −3 |
| Q4 2024 | 10 | -2 | 5.93M | $144.12M | +1 | −3 |
| Q3 2024 | 11 | +1 | 5.51M | $204.79M | +2 | −1 |
| Q2 2024 | 10 | — | 5.61M | $267.04M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.05M | — | $49.86M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.17M | 0.0% | $28.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.17M | 0.0% | $28.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 1.15M | -21.0% | $28.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 759.14K | -9.9% | $18.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 321.52K | -65.6% | $7.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 321.52K | -65.6% | $7.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 152.55K | -55.7% | $3.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 138.10K | -54.6% | $3.35M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 94.88K | +4.6% | $2.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 94.88K | +4.6% | $2.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 50.25K | New | $1.22M | 0.0% | New | 1 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 35.61K | +9.4% | $866,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $1.22M | 0.0% |
Exited
| Norges Bank | $10.12M | was 0.0% |
| Two Sigma Investments | $1.39M | was 0.0% |
| Bridgewater Associates | $716,289 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 186 holders, 53.87M shares, $998.22M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.